- Home
- ORIC vs ASTH Comparison
ORIC vs ASTH Comparison
Compare ORIC & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- ASTH
- Stock Information
- Founded
- ORIC 2014
- ASTH 1994
- Country
- ORIC United States
- ASTH United States
- Employees
- ORIC N/A
- ASTH N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- ASTH Professional Services
- Sector
- ORIC Health Care
- ASTH Consumer Discretionary
- Exchange
- ORIC Nasdaq
- ASTH Nasdaq
- Market Cap
- ORIC 1.1B
- ASTH 1.1B
- IPO Year
- ORIC 2020
- ASTH N/A
- Fundamental
- Price
- ORIC $11.54
- ASTH $22.51
- Analyst Decision
- ORIC Strong Buy
- ASTH Strong Buy
- Analyst Count
- ORIC 11
- ASTH 7
- Target Price
- ORIC $18.78
- ASTH $45.29
- AVG Volume (30 Days)
- ORIC 1.1M
- ASTH 624.6K
- Earning Date
- ORIC 11-13-2025
- ASTH 11-06-2025
- Dividend Yield
- ORIC N/A
- ASTH N/A
- EPS Growth
- ORIC N/A
- ASTH N/A
- EPS
- ORIC N/A
- ASTH 0.20
- Revenue
- ORIC N/A
- ASTH $2,896,452,000.00
- Revenue This Year
- ORIC N/A
- ASTH $60.87
- Revenue Next Year
- ORIC N/A
- ASTH $27.04
- P/E Ratio
- ORIC N/A
- ASTH $115.17
- Revenue Growth
- ORIC N/A
- ASTH 68.17
- 52 Week Low
- ORIC $3.90
- ASTH $20.12
- 52 Week High
- ORIC $14.93
- ASTH $45.16
- Technical
- Relative Strength Index (RSI)
- ORIC 40.39
- ASTH 37.11
- Support Level
- ORIC $11.28
- ASTH $20.78
- Resistance Level
- ORIC $12.50
- ASTH $24.50
- Average True Range (ATR)
- ORIC 0.82
- ASTH 1.91
- MACD
- ORIC -0.16
- ASTH -0.63
- Stochastic Oscillator
- ORIC 22.22
- ASTH 17.07
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.